These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28478778)

  • 1. Investigation of serum levels of sortilin in response to antidepressant treatment.
    Buttenschøn HN; Nielsen M; Glerup S; Mors O
    Acta Neuropsychiatr; 2018 Apr; 30(2):111-116. PubMed ID: 28478778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients.
    Devader C; Roulot M; Moréno S; Minelli A; Bortolomasi M; Congiu C; Gennarelli M; Borsotto M; Heurteaux C; Mazella J
    J Affect Disord; 2017 Jan; 208():443-447. PubMed ID: 27838145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.
    Stelzhammer V; Guest PC; Rothermundt M; Sondermann C; Michael N; Schwarz E; Rahmoune H; Bahn S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1199-207. PubMed ID: 23183131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect of antidepressant treatment on elevated serum ceruloplasmin level in patients with first-episode depression: a longitudinal study.
    Kaya MC; Bez Y; Selek S; Fatih Karababa I; Bulut M; Savaş HA; Celik H; Herken H
    Arch Med Res; 2012 May; 43(4):294-7. PubMed ID: 22704847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF.
    Buttenschøn HN; Demontis D; Kaas M; Elfving B; Mølgaard S; Gustafsen C; Kaerlev L; Petersen CM; Børglum AD; Mors O; Glerup S
    Transl Psychiatry; 2015 Nov; 5(11):e677. PubMed ID: 26556286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
    Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
    J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.
    Fiori LM; Lopez JP; Richard-Devantoy S; Berlim M; Chachamovich E; Jollant F; Foster J; Rotzinger S; Kennedy SH; Turecki G
    Int J Neuropsychopharmacol; 2017 Aug; 20(8):619-623. PubMed ID: 28520926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study.
    Halmai Z; Dome P; Dobos J; Gonda X; Szekely A; Sasvari-Szekely M; Faludi G; Lazary J
    J Affect Disord; 2013 Jan; 144(3):269-73. PubMed ID: 23021824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
    Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can people with nonsevere major depression benefit from antidepressant medication?
    Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants.
    Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y
    Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine serum levels remain unchanged during lithium augmentation of antidepressants in major depression.
    Ricken R; Busche M; Schlattmann P; Himmerich H; Bopp S; Bschor T; Richter C; Stamm TJ; Heinz A; Hellweg R; Lang UE; Adli M
    J Psychiatr Res; 2018 Jan; 96():203-208. PubMed ID: 29101798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.
    Yang JJ; Wang N; Yang C; Shi JY; Yu HY; Hashimoto K
    Biol Psychiatry; 2015 Feb; 77(3):e19-e20. PubMed ID: 25104172
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring the sortilin related receptor, SorLA, in depression.
    Buttenschøn HN; Elfving B; Nielsen M; Skeldal S; Kaas M; Mors O; Glerup S
    J Affect Disord; 2018 May; 232():260-267. PubMed ID: 29499509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between baseline severity of depression and antidepressant treatment outcome.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Riedel M; Möller HJ
    Pharmacopsychiatry; 2011 Jan; 44(1):27-32. PubMed ID: 20981642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.
    Bauer M; Thase ME; Liu S; Earley W; Eriksson H
    J Psychopharmacol; 2015 May; 29(5):565-74. PubMed ID: 25257148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy.
    Rivera-Baltanas T; Olivares JM; Martinez-Villamarin JR; Fenton EY; Kalynchuk LE; Caruncho HJ
    J Affect Disord; 2014 Jul; 163():47-55. PubMed ID: 24836087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.